Mark Romich

Title: Mark Romich: Innovator in Pancreatin Manufacturing

Introduction

Mark Romich is a notable inventor based in New Glarus, Wisconsin. He has made significant contributions to the field of pancreatin manufacturing, holding 2 patents that focus on reducing viral and microbial content in the production processes.

Latest Patents

Romich's latest patents include a method for reducing or inactivating viral and microbial content in the processes for the manufacture of pancreatin. This innovative method involves a pancreatin preparation that has reduced viral infectivity, which includes one or more pancreatin enzymes and peracetic acid (PAA). At least one of these enzymes may be derived from an animal source, such as a porcine pancreas gland. Additionally, he has developed a method for treating animal-derived tissue with peracetic acid to reduce viral activity and bacterial load prior to processing. This method specifically treats porcine pancreas glands before extracting a pancreatin active pharmaceutical ingredient (API) from the treated glandular tissue.

Career Highlights

Mark Romich is currently associated with Scientific Protein Laboratories, LLC, where he continues to advance his research and innovations in the field. His work has been instrumental in enhancing the safety and efficacy of pancreatin products.

Collaborations

Some of his notable coworkers include Kenneth S Manning and Yan Wang, who contribute to the collaborative efforts in research and development at Scientific Protein Laboratories.

Conclusion

Mark Romich's contributions to pancreatin manufacturing through his innovative patents highlight his commitment to improving safety in pharmaceutical processes. His work continues to impact the industry positively.